Publications
Filters: First Letter Of Last Name is P [Clear All Filters]
“Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant falciparum malaria in pregnancy:a preliminary report”, in 5th European Congress on Tropical Medicine and International Health, Amsterdam, the Netherlands, 2007, vol. 12, p. 34.
, “Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study”, Malar J, vol. 17, no. 1, p. 427, 2018.
, “Paracheck-Pf: a new, inexpensive and reliable rapid test for P. falciparum malaria”, Tropical Medicine and International Health, vol. 6, no. 2, pp. 99-101., 2001.
, “Considerations on the use of nucleic acid-based amplification for malaria parasite detection”, Malar J, vol. 10, no. 1, p. 323, 2011.
, “A Survey of Practice and Knowledge of Refugee and Migrant Pregnant Mothers Surrounding Neonatal Jaundice on the Thailand-Myanmar Border”, J Trop Pediatr, vol. 63, no. 1, pp. 50-56, 2017.
, “Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 4, pp. 547-55, 1999.
, “Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis”, The Lancet Infectious Diseases, 2014.
, “Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 6, pp. 883-8, 1998.
, “Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number”, Lancet, vol. 364, no. 9432, pp. 438-47, 2004.
, “Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria”, Antimicrob Agents Chemother, vol. 43, no. 2, pp. 341-6, 1999.
, “Effects of artemisinin derivatives on malaria transmissibility”, Lancet, vol. 347, pp. 1654-8, 1996.
, “Factors contributing to anemia after uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 614-22., 2001.
, “Artesunate and mefloquine in the treatment of uncomplicated multidrug- resistant hyperparasitaemic falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 207-11, 1998.
, “Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria”, Clin Infect Dis, vol. 42, no. 11, pp. 1570-7, 2006.
, “Risk factors for gametocyte carriage in uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 1019-23, 1999.
, “Single-dose radical cure of Plasmodium vivax: A step closer”, The Lancet, vol. 383, no. 9922, pp. 1020-1021, 2014.
, “Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 5, pp. 574-7, 1997.
, “Antimalarial therapies in children from Papua New Guinea”, N Engl J Med, vol. 360, no. 12, p. 1254; author reply 1255, 2009.
, “Drug resistant falciparum malaria: clinical consequences and strategies for prevention”, Drug Resistance Updates, vol. 4, no. 3, pp. 187-96., 2001.
, “Assessment of pfmdr 1 gene copy number by tandem competitive polymerase chain reaction”, Mol Biochem Parasitol, vol. 85, no. 2, pp. 161-9, 1997.
, “The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand”, Antimicrob Agents Chemother, vol. 43, no. 12, pp. 2943-9, 1999.
, “Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 5, pp. 523-7, 1995.
, “World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs”, Malar J, vol. 6, p. 119, 2007.
, “Prolongation of the QTc interval in African children treated for falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 4, p. 503, 1998.
, “A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains”, Nat Commun, vol. 5, p. 4052, 2014.
, “PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation”, J Infect Dis, vol. 209, no. 11, pp. 1808-15, 2014.
, “VarB: a variation browsing and analysis tool for variants derived from next-generation sequencing data”, Bioinformatics, vol. 28, no. 22, pp. 2983-2985, 2012.
, “Closing the translation gap for justice requirements in international research”, J Med Ethics, vol. 38, no. 9, pp. 552-558, 2012.
, “Exploitation and community engagement: can community advisory boards successfully assume a role minimising exploitation in international research?”, Dev World Bioeth, vol. 15, no. 1, pp. 18-26, 2015.
, “Ancillary Care: From Theory to Practice in International Clinical Research”, Public Health Ethics, vol. 6, no. 2, pp. 154-169, 2013.
, “Linking international clinical research with stateless populations to justice in global health”, BMC Med Ethics, vol. 15, no. 1, p. 49, 2014.
, “Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship”, Malar J, vol. 10, no. 1, p. 374, 2011.
, “Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic”, Clin Infect Dis, vol. 46, no. 9, pp. 1374-81, 2008.
, “Low seroprevalence of HIV and syphilis in pregnant women in refugee camps on the Thai-Burma border”, Int J STD AIDS, vol. 19, no. 12, pp. 833-7, 2008.
, “Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria”, Malar J, vol. 16, no. 1, p. 134, 2017.
, “Efficacy and safety of quinine vs artemether-lumefantrine in uncomplicated malaria during pregnancy, Mbarara, Uganda”, in 58th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2009, vol. 81, p. 8.
, “Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial”, The Lancet Infectious Diseases, vol. 10, no. 11, pp. 762-769, 2010.
, “Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar”, Malaria Journal, vol. 19, no. 1, p. 315, 2020.
, “Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins”, Parasite, vol. 2, no. 3, pp. 263-8, 1995.
, “Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors”, Clin Infect Dis, vol. 63, no. 6, pp. 784-91, 2016.
, “Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial”, Lancet Infect Dis, 2015.
, “Dihydroartemisinin-Piperaquine Versus Chloroquine in the Treatment of Plasmodium vivax Malaria in Thailand: A Randomized Controlled Trial”, Clin Infect Dis, vol. 53, no. 10, pp. 977-84, 2011.
, “Challenges to replace ACT as first-line drug”, Malar J, vol. 16, no. 1, p. 296, 2017.
, “Poor response to artesunate treatment in two patients with severe malaria on the Thai-Myanmar border”, Malar J, vol. 17, no. 1, p. 30, 2018.
, “Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials”, PLoS One, vol. 15, no. 2, p. e0228190, 2020.
, “Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria”, International Journal of Clinical Pharmacology and Therapeutics, vol. 37, no. 1, pp. 58-61, 1999.
, “Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis”, PLOS Medicine, vol. 17, no. 5, p. e1003084, 2020.
, “Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine”, Antimicrob Agents Chemother, 2017.
, “Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region”, PLoS One, vol. 14, no. 3, p. e0214280, 2019.
, “Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials”, Malar J, vol. 18, no. 1, p. 428, 2019.
, “Genomic analysis of local variation and recent evolution in Plasmodium vivax”, Nat Genet, vol. advance online publication, 2016.
, “Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand”, The American Journal of Tropical Medicine and Hygiene, vol. 58, no. 2, pp. 195-203, 1998.
, “Genetic analysis of Plasmodium falciparum infections on the north- western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 6, pp. 587-93, 1999.
, “Evaluation of a new Plasmodium lactate dehydrogenase assay (OptiMAL-IT) for the detection of malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 6, pp. 672-4, 2003.
, “Clinical audit to enhance safe practice of skilled birth attendants for the fetus with nuchal cord: evidence from a refugee and migrant cohort”, BMC Pregnancy Childbirth, vol. 14, no. 1, p. 76, 2014.
, “Trends and birth outcomes in adolescent refugees and migrants on the Thailand-Myanmar border, 1986-2016: an observational study”, Wellcome Open Research, vol. 3, 2018.
, “Malaria ecology along the Thailand-Myanmar border”, Malar J, vol. 14, no. 1, p. 388, 2015.
, “Herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations and the implications for malaria elimination”, bioRxiv, p. 393843, 2018.
, “A multi-level spatial analysis of clinical malaria and subclinical Plasmodium infections in Pailin Province, Cambodia”, Heliyon, vol. 3, no. 11, p. e00447, 2017.
, “Limitations of malaria reactive case detection in an area of low and unstable transmission on the Myanmar-Thailand border”, Malar J, vol. 15, no. 1, p. 571, 2016.
, “Potential herd protection against Plasmodium falciparum infections conferred by mass antimalarial drug administrations”, Elife, vol. 8, 2019.
, “Scale up of a Plasmodium falciparum elimination program and surveillance system in Kayin State, Myanmar [version 2; referees: 2 approved]”, Wellcome Open Res, vol. 2, no. 98, 2017.
, “Microgeography and molecular epidemiology of malaria at the Thailand-Myanmar border in the malaria pre-elimination phase”, Malar J, vol. 14, p. 198, 2015.
, “Singapore's Anopheles sinensis Form A is susceptible to Plasmodium vivax isolates from the western Thailand-Myanmar border”, Malar J, vol. 16, no. 1, p. 465, 2017.
, “Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient”, Am J Trop Med Hyg, vol. 100, no. 1. pp. 213-221, 2018.
, “Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient”, Am J Trop Med Hyg, vol. 100, no. 1, pp. 213-221, 2019.
,